Elon Musks’s neurotechnology company Neuralink announced on Thursday it has obtained approval from the U.S. Food and Drug Administration (FDA) to carry out a clinical study of brain implants in humans. It marks the first in-human clinical study for the company. “This is the result of incredible work by the Neuralink team in close collaboration with

Leave a Reply